Risk of discontinuation of antipsychotic long‐acting injections vs. oral antipsychotics in real‐life prescribing practice: a community‐based study. (23rd March 2017)
- Record Type:
- Journal Article
- Title:
- Risk of discontinuation of antipsychotic long‐acting injections vs. oral antipsychotics in real‐life prescribing practice: a community‐based study. (23rd March 2017)
- Main Title:
- Risk of discontinuation of antipsychotic long‐acting injections vs. oral antipsychotics in real‐life prescribing practice: a community‐based study
- Authors:
- Verdoux, H.
Pambrun, E.
Tournier, M.
Bezin, J.
Pariente, A. - Abstract:
- Abstract : Objective: To compare the risk of discontinuation of ambulatory antipsychotic treatment in persons treated with antipsychotic long‐acting injections (LAIs) or by oral antipsychotics (OAPs). Methods: The study was performed in a representative sample of persons newly treated with OAPs ( n = 6904) affiliated to the French Insurance Healthcare system. The risk of all‐cause discontinuation was compared in patients prescribed OAPs ( n = 246) vs. matched patients prescribed LAIs ( n = 246) using multivariate survival analyses. Confounding by indication was minimized by matching on type of antipsychotic drug and by the high‐dimensional propensity score method. Results: Discontinuation was more frequent with OAPs (69%) compared to LAIs (57%) [adjusted relative risk (aRR) = 1.6, 95% CI 1.23–2.07]. Risk of discontinuation was higher for first‐generation (FGA) OAPs vs. FGA LAIs (aRR = 1.94, 95% CI 1.22–3.08) as well as for second‐generation (SGA) OAPs vs. SGA LAIs (aRR = 1.58, 95% CI 1.15–2.17). Over the 6‐month period after discontinuation of LAIs, a new antipsychotic drug was dispensed in 58% of patients, the most frequent pattern being dispensing of the same LAI as that prescribed before discontinuation. Conclusions: Although less frequent than with OAPs, the rate of ambulatory treatment discontinuation was high with LAIs. Prescription of LAIs should be associated with intervention strategies aimed at promoting medication adherence.
- Is Part Of:
- Acta psychiatrica Scandinavica. Volume 135:Number 5(2017:May)
- Journal:
- Acta psychiatrica Scandinavica
- Issue:
- Volume 135:Number 5(2017:May)
- Issue Display:
- Volume 135, Issue 5 (2017)
- Year:
- 2017
- Volume:
- 135
- Issue:
- 5
- Issue Sort Value:
- 2017-0135-0005-0000
- Page Start:
- 429
- Page End:
- 438
- Publication Date:
- 2017-03-23
- Subjects:
- antipsychotic long‐acting injection -- first‐generation antipsychotic -- second‐generation antipsychotic -- discontinuation
Psychiatry -- Periodicals
616.89 - Journal URLs:
- http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=acp ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1600-0447 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/acps.12722 ↗
- Languages:
- English
- ISSNs:
- 0001-690X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0661.470000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 4.xml